Cardiac output (CO) monitoring is an invaluable tool for management of critically ill patients in the intensive care units (ICU) and high-risk patients undergoing surgery.
Measurements of CO were not available until 1970, when Swan et al introduced the flow-directed balloon-tipped pulmonary artery catheter (PAC); this catheter is inserted at the bedside and is considered the gold standard for accurate CO measurements 1, 2 . Recently, minimally invasive and non-invasive alternative CO monitors have emerged that not only overcome the PAC's invasive limitations, but are also able to guide fluid optimization, which has been shown to improve the outcome after major surgery 3 .
This is a review of the characteristics of the PAC and compares it with other less invasive and non-invasive CO monitors currently available.
We will look at issues of accuracy, dependability, complications, limitations to use, the ability to give continuous readings and how these monitoring systems could be used to guide fluid status optimization.
The systems we will review include the following: The PAC involves introducing a balloon-tipped catheter into the superior vena cava through one of the central veins, through the right side of the heart and into the pulmonary circulation. Inflation of the balloon would allow the catheter to float in the pulmonary circulation until it wedges in a distal branch Since it was the first modality to measure the CO accurately, it gained immense popularity among anesthetists and intensivists.
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It was used as a diagnostic tool in critically ill patients, such as for differentiating between cardiogenic and non-cardiogenic pulmonary edema, evaluating pulmonary artery hypertension (PAH), atrial septal defects (ASD), ventricular septal defects (VSD), mitral regurgitation, cardiac tamponade and restrictive cardiomyopathy (RCM). In addition, it was found to be helpful in guiding fluid infusions, inotropes and vasopressor therapies in shock, heart failure, renal failure and cardiac surgery patients 4, 5 .
However, with increased use, various complications, such as thromboembolism, pulmonary valvular endocarditis, air embolism, pulmonary hemorrhage, pulmonary infarction and distal pulmonary artery rupture were recognized 4, [6] [7] [8] . In recent years, its usefulness has been questioned as many trials have shown conflicting results regarding both benefit and mortality [9] [10] [11] [12] [13] [14] [15] .
With the availability of less invasive hemodynamic monitoring tools, its use has significantly declined and is mostly limited to diagnosis and perioperative management of patients with PAH and intracardiac shunts 16 .
LiDCO Plus ™ (LiDCO Ltd, London, UK)
The LiDCO Plus ™ requires the insertion of an arterial line and a peripheral/central venous line.
It is a continuous CO monitor utilizing the lithium indicator dilution cardiac output (LiDCO ™ ), and the pulse CO realtime technology (Pulse CO ™ ).
The LiDCO
™ measures the CO intermittently and accurately by using the indicator dilution technique, where intravenous lithium acts as the indicator (using the Fick's principle as in PAC).
The Pulse CO ™ measures mean arterial pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), stroke volume (SV) and CO continuously on beat-by-beat by analyzing the whole arterial waveform. It also has the advantage of monitoring the preload responsiveness parameters including the stroke volume variation (SVV) and the pulse pressure variation (PPV) 17 .
The CO measurements generated by the LiDCO ™ component are used to calibrate the CO measurements obtained by the Pulse CO ™ once every 8 hours. After calibration, the Pulse CO ™ would provide a reliable, continuous beat-by-beat CO measurement. It is widely validated for its accuracy regarding CO monitoring [17] [18] [19] [20] [21] [22] .
However, LiDCO Plus ™ could not be used in patients weighing ˂ 40 kg, pregnant and those on oral lithium medications. Its measurements are unreliable in patients receiving muscle relaxant infusions 23, 24 . It is time-consuming, and staff would require training in order to perform the calibration.
LiDCO Rapid
™ (LiDCO Ltd, London, UK)
The LiDCO Rapid ™ is a new monitor technically identical to the Pulse CO ™ component of the LiDCO Plus ™ monitor, only requiring the insertion of an arterial line. The LiDCO Rapid ™ is compact, easily applied and does not require lithium calibration; therefore, it avoids the limitations of LiDCO Plus ™ . This device does not provide absolute estimates of the CO; however, it tracks the trend of change in flow and resistance, thus, providing continuous monitoring of the BP, HR, SV, CO and also preload responsiveness parameters (SVV and PPV). The TPTD technique is used intermittently to obtain accurate estimates of the CO. Cold saline is injected into the superior vena cava via a central venous line, and the change in temperature downstream is measured in the femoral artery via a femoral arterial catheter.
PiCCO Plus
The CO measurements generated by the TPTD component are used to calibrate the CO measurements obtained by the pulse contour once every 8 hours. After calibration, the pulse contour would provide a reliable continuous beat-by-beat CO measurement. The PiCCO Plus ™ is widely validated for its accuracy 25 .
In addition to the parameters assessed by the LiDCO Plus ™ , the PiCCO Plus ™ measures the cardiac function index (CFI), global end-diastolic volume (GEDV), Global ejection fraction (GEF), intra-thoracic blood volume (ITBV) and extra-vascular lung water (EVLW). These parameters could help the clinician at the bedside to determine whether the pulmonary edema is of cardiogenic origin or not, the volume of blood in the cardiac chambers (which reflects the volume status of the patient) and the amount of pulmonary edema fluid [26] [27] [28] . 
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Esophageal Doppler Ultrasound
A flexible probe containing a Doppler ultrasound in its tip is inserted orally into the esophagus and is positioned at the midthoracic level. It measures the flow of blood in the descending aorta and estimates the CO by multiplying the velocity of the blood flow with the cross-sectional area of the aorta. It measures the SV, CO and SVR [32] [33] [34] .
Finometer
™ (Finapres Medical Systems, Amsterdam, Netherlands)
The Finometer ™ is a non-invasive, beat-by-beat hemodynamic monitor that generates a continuous pulse waveform using a finger cuff, which is then computed to provide continuous blood pressure and CO measurements. The continuous BP measurements are further calibrated against the brachial arterial pressure [35] [36] [37] [38] [39] [40] .
This device is accurate regarding BP monitoring and tracking the trends of change in CO. It could not be used in conditions associated with hypoperfusion of the extremities and in patients below six years of age [41] [42] [43] [44] [45] [46] .
The Nexfin ™ is similar in principle to the Finometer ™ . It also measures the hemodynamics continuously through a finger cuff with a similar level of accuracy 47 . The Nexfin 
